HIV Medicine Association

10/13/2026

How is HIV treatment evolving, and what will it take to sustain progress in 2026 and beyond?

Join the session, “State-of-the-Art HIV Treatment” to explore advances in long-acting injectable and oral antiretroviral regimens, investigational therapies and novel delivery platforms, and strategies to overcome barriers to global HIV care.

Register for IDWeek: https://www.idweek.org/registration/

10/10/2026

On National PrEP Day, we’re highlighting a powerful tool in HIV prevention. PrEP is highly effective at preventing HIV, yet access remains inequitable, particularly among communities disproportionately affected by HIV. We must continue working to make PrEP accessible, affordable and stigma-free for everyone.

Learn more this :

National PrEP Day on October 10 raises vital awareness about PrEP (pre-exposure prophylaxis), a highly effective medication for preventing HIV transmission. Learn more.

10/09/2026

Join “Your Voice, Your Patients, Your Community: ID and HIV Advocacy in an Election Year” at to hear from HIVMA advocates about engaging Congress on key ID and HIV priorities and learn how the 2026 midterm elections could shape future funding and policy efforts.

RSVP here: https://bit.ly/4rVsL2t

10/07/2026

What do you do when HIV treatment and prevention cases don’t have easy answers?

Join the session, “Challenging HIV Treatment and Prevention Clinical Cases” to work through complex cases involving antiretroviral resistance, drug interactions, treatment failure and more.

Register for IDWeek: https://www.idweek.org/registration/

10/07/2026

Delays in renewing federal funding for four major HIV research networks raise concerns about the future of critical HIV clinical trials and research. https://nyti.ms/4hLFMXL

Our recent press briefing explores how federal funding delays could impact scientific progress: https://bit.ly/4h5UQAp

Experts in infectious diseases will discuss how delays in—and the potential withholding of—federal funding for the HIV/AIDS Clinical Trials Networks could impact scientific progress. 

10/04/2026

The Panel on Antiretroviral Guidelines for Adults and Adolescents updated the HIV treatment guidelines on Sept. 24, with revisions covering What to Start, Optimizing Antiretroviral Therapy, Adolescents and Young Adults With HIV, Substance Use Disorders, Women With HIV and more.

See what’s new:

Updates to the HIV and AIDS treatment recommendations developed by a panel of experts on the use of antiretroviral agents in adults and adolescents with HIV.

10/02/2026

Help shape the future of HCV screening coverage.

CMS is reviewing Medicare’s coverage of HCV screening for adults ages 18–79 and seeking input on screening intervals and screening in non-primary care settings.

Learn more and submit your comments by Oct. 23:

Use this page to view the details for the NCA - Screening for Hepatitis C Virus (HCV) in Adults (CAG-00436R) - Tracking Sheet

10/01/2026

Explore the connections between HIV, STIs and substance use disorders at . Join “A Syndemic Approach: Great Cases in HIV, STIs and Substance Use Disorders” for a case-based look at these intersecting areas of care.

Learn more and register for IDWeek: https://cdmcd.co/GwYAyX

09/27/2026

09/27/2026

Today marks National Gay Men’s HIV/AIDS Awareness Day, an opportunity to raise awareness about the disproportionate impact of HIV on gay and bisexual men and work toward ending HIV stigma.

Learn more this : https://bit.ly/4xO6Yen